PAVmed Inc. Stock: price and insider trades · United States

Every trade that managers of PAVmed Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for PAVmed Inc. logged 10 filings by 10 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

No insider has bought PAVmed Inc. shares on the open market in the past twelve months. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4.

Compared with its exchange (5,458 companies, median 22 filings), a count of 10 filings is below the norm. Since 2022, the database holds 1 purchase and no sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.